Malignant Salivary Gland Neoplasm — Trials

Malignant Salivary Gland Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

225 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 63
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 21.4%
Trials / 1,000 deaths: 56.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–25 of 25 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06462183	Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)	active not recruiting	Phase 1	105	Rgenta Therapeutics IncINDUSTRY	2	Sep 17, 2026	clinicaltrials
NCT04140526	Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC(PRESERVE-001)	active not recruiting	Phase 1 / Phase 2	733	OncoC4, Inc.INDUSTRY	2	Sep 14, 2026